Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Ramipril × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 1 Cognitive Dysfunction 1 Brain Neoplasms 1

Interventions

Patient Reported Outcome Measures 2 Neuropsychological Tests 2 lithium sulfate 1 XENP 1595 1 Sodium Chloride 1 Ramipril 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Quality of Life 1 Pioglitazone 1 Mental Status and Dementia Tests 1 Memantine 1 Lithium 1 G(M1) Ganglioside 1 Donepezil 1 Climate Anxiety 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03475186 2026-03-13

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Wake Forest University Health Sciences

Phase 2 Completed

75 enrolled 47 charts

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡